Scinai Immunotherapeutics Statistics
Total Valuation
SCNI has a market cap or net worth of $1.99 million. The enterprise value is $5.48 million.
| Market Cap | 1.99M |
| Enterprise Value | 5.48M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SCNI has 4.35 million shares outstanding. The number of shares has increased by 140.18% in one year.
| Shares Outstanding | 4.35M |
| Shares Change (YoY) | +140.18% |
| Shares Change (QoQ) | +38.84% |
| Owned by Insiders (%) | 24.21% |
| Owned by Institutions (%) | 10.63% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.36
| Current Ratio | 4.36 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 4.19 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -49.30% |
| Return on Capital (ROIC) | -85.62% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$331,892 |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.40% in the last 52 weeks. The beta is 2.45, so SCNI's price volatility has been higher than the market average.
| Beta (1Y) | 2.45 |
| 52-Week Price Change | -75.40% |
| 50-Day Moving Average | 0.49 |
| 200-Day Moving Average | 0.78 |
| Relative Strength Index (RSI) | 44.56 |
| Average Volume (30 Days) | 26,417 |
Short Selling Information
The latest short interest is 22,536, so 0.52% of the outstanding shares have been sold short.
| Short Interest | 22,536 |
| Short Previous Month | 5,506 |
| Short % of Shares Out | 0.52% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.84 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.83M |
| Pretax Income | -2.86M |
| Net Income | -10.95M |
| EBITDA | n/a |
| EBIT | -3.76M |
| Earnings Per Share (EPS) | -$1.29 |
Balance Sheet
The company has $1.70 million in cash and $5.18 million in debt, giving a net cash position of -$3.48 million or -$0.80 per share.
| Cash & Cash Equivalents | 1.70M |
| Total Debt | 5.18M |
| Net Cash | -3.48M |
| Net Cash Per Share | -$0.80 |
| Equity / Book Value | -703,734 |
| Book Value Per Share | -0.16 |
| Working Capital | 1.35M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SCNI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -140.18% |
| Shareholder Yield | -140.18% |
| Earnings Yield | -549.74% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 25, 2022. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 25, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |